Artículos del autor

solaci

Structural heart disease

Cerebral Embolic Protection Devices: How Useful are they in TAVR?

During TAVR, we often fear the possibility of a stroke, which occurs in approximately 1 – 2%...
solaci -
Structural heart disease

Is TAVR Beneficial in Cardiogenic Shock?

The presence of cardiogenic shock (CS) in a setting of aortic stenosis ranges from 1% to 4%....
solaci -
Antithrombotic Anticoagulants

Acute Pulmonary Thromboembolism: When Anticoagulation Alone May Not Be Enough

In recent times, pulmonary thromboembolism (PTE) has been the subject of growing research due to its persistent...
solaci -
Peripheral vascular disease

Renal Denervation is Safe and Reduces Blood Pressure and Medication

We are well aware of the multifactorial nature of hypertension, as well as the fact that it...
solaci -
Events

18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism to Start This Week

On November 9 thru 11, 2023, the 18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism will be...
solaci -
Structural heart disease

Impella in High Risk Coronary Angioplasty before TAVR

The population is aging, which is closely related with the presence of aortic stenosis. This condition, as...
solaci -
Events

November 17 and 18: SOVECI 20th Annual Meeting, 2023

We invite the entire community to take part in the annual meeting of the Venezuelan Society of...
solaci -
Coronary disease

Low vs High Dose Drug Coated Balloons in Femoropopliteal Territory

The use of drub coated balloons (DCB) in the treatment of femoropopliteal artery disease has grown. Studies...
solaci -